Amin Pharmaceutical Co (XTEH:AMIN1) Dividend Yield %: 2.55% (As of Sep. 02, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Amin Pharmaceutical Co Dividend Yield %?

Amin Pharmaceutical Co XTEH:AMIN1 Dividend Yield % is 2.55% as of Sep. 02, 2026.

As of today (2026-09-02), the Trailing Annual Dividend Yield of Amin Pharmaceutical Co is 2.55%.

The historical rank and industry rank for Amin Pharmaceutical Co's Dividend Yield % or its related term are showing as below:

XTEH:AMIN1' s Dividend Yield % Range Over the Past 10 Years
Min: 0   Med: 0   Max: 2.55
Current: 2.55

During the past 0 years, the highest Dividend Yield of Amin Pharmaceutical Co was 2.55%. The lowest was 0.00%. And the median was 0.00%.

XTEH:AMIN1's Dividend Yield % is not ranked
in the Drug Manufacturers industry.
Industry Median: 2 vs XTEH:AMIN1: 2.55

Amin Pharmaceutical Co's Dividend Payout Ratio for the six months ended in . 20 was 0.00.

As of today (2026-09-02), the Forward Dividend Yield % of Amin Pharmaceutical Co is 2.55%.

Amin Pharmaceutical Co's Dividends per Share for the six months ended in . 20 was IRR0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.

Amin Pharmaceutical Co  (XTEH:AMIN1) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.

Amin Pharmaceutical Co Dividend Yield % Related Terms

Amin Pharmaceutical Co Dividend Yield % Historical Data

* Premium members only.

The historical data trend for Amin Pharmaceutical Co's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Amin Pharmaceutical Co Dividend Yield % Chart

Amin Pharmaceutical Co Annual Data
Trend
Dividend Yield %

Amin Pharmaceutical Co Semi-Annual Data
Dividend Yield %

XTEH:AMIN1 vs : Dividend Yield % Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Amin Pharmaceutical Co's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Amin Pharmaceutical Co Dividend Yield % vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Amin Pharmaceutical Co's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Amin Pharmaceutical Co's Dividend Yield % falls into.


Amin Pharmaceutical Co Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

Frequently Asked Questions Learn more about Dividend Yield % →
What does a Dividend Yield % of 2.55% mean?
Amin Pharmaceutical Co (XTEH:AMIN1) has a Dividend Yield % of 2.55% as of Sep. 02, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Amin Pharmaceutical Co and its competitors.
Is Amin Pharmaceutical Co's Dividend Yield % too high?
Amin Pharmaceutical Co's current Dividend Yield % is 2.55%. The Drug Manufacturers industry median Dividend Yield % is 2.00. Amin Pharmaceutical Co's value of 2.55% is 27.5% above this industry median.
How does Amin Pharmaceutical Co's Dividend Yield % compare to ?
Amin Pharmaceutical Co's Dividend Yield % of 2.55% can be compared against companies in the Drug Manufacturers industry. The industry median Dividend Yield % is 2.00. Amin Pharmaceutical Co's value of 2.55% is 27.5% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Drug Manufacturers company?
The median Dividend Yield % among Drug Manufacturers companies is 2.00, based on 508 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Amin Pharmaceutical Co's current Dividend Yield % of 2.55% is 27.5% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Amin Pharmaceutical Co and its competitors. For the Drug Manufacturers industry, the median Dividend Yield % is 2.00 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Amin Pharmaceutical Co's current Dividend Yield % is 2.55%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Amin Pharmaceutical Co stock overvalued right now?
Amin Pharmaceutical Co (XTEH:AMIN1) has a current Dividend Yield % of 2.55%. The current Dividend Yield % is 2.55% and 27.5% above the Drug Manufacturers industry median of 2.00. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Amin Pharmaceutical Co (XTEH:AMIN1), the current Dividend Yield % is 2.55% as of Sep. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Amin Pharmaceutical Co Business Description

Comparable Companies
Address Abolfazl Street, Bostan Heftam West Alley, No. 4, 2nd floor, Marzdaran, Tehran, IRN
Amin Pharmaceutical Co is engaged in the manufacturing of pharmaceutical products, chemical drugs, herbal medicines, and nutritional supplements. It offers antimicrobials, cardiovascular, antidiabetic, cerebellar, gastrointestinal, antibiotic and antifungal, and hypoglycemic agents among others. It develops drugs in the form of plain and overlaid tablets, hard, and soft capsules, oral drops, syrups, and suspensions. Products offered by the company include Acarbose, Sitagliptin, Fampridine, Ofloxacin, Amiodarone, Ibuprofen, Zolpidem, Bilberry, Thyme, and others. Amin also exports its products to Afghanistan, Kazakhstan, Uzbekistan, and Iraq.